Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Technilab Pharma Inc.

Division of Teva Pharmaceutical Industries Ltd.

Latest From Technilab Pharma Inc.

Neuer Markt Drives German Shopping Spree

Capitalizing on their hefty valuations, German public biotechs are going on a shopping spree, swapping stock for other companies and thereby creating broader platforms of technologies and in some cases clinical pipelines. In their zest for turning their paper into harder industrial assets, German biotechs are showing themselves far more aggressive than the majority of their American and British counterparts.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Jean-Guy Sabourin, Pres. & CEO
    Marc Baillargoon, EVP, Fin., Admin. & CFO
    Jean-Guy Goulet, VP, Bus. Dev.
    Hani Kafoury, VP, Mktg.
    Ela Borenstein, VP, Scientific Affairs
    Vincent Tellefer, VP, Corp. Dev. & Investor Relations
  • Contact Info
  • Technilab Pharma Inc.
    Phone: (514) 433-7673
    17800 Lapointe St.
    Mirabel, J7J 1P3